| 1 |
2D 13C-13C with fpRFDR |
1-2 mg selectively and uniformly labeled samples beta-amyloid peptide |
10 |
none |
7.4 |
ambient |
288 |
| 2 |
2D and 3D NCACX |
1-2 mg selectively and uniformly labeled samples beta-amyloid peptide |
10 |
none |
7.4 |
ambient |
288 |
| 3 |
2D NCOCX |
1-2 mg selectively and uniformly labeled samples beta-amyloid peptide |
10 |
none |
7.4 |
ambient |
288 |
| 4 |
3D NCOCX |
1-2 mg selectively and uniformly labeled samples beta-amyloid peptide |
10 |
none |
7.4 |
ambient |
288 |
| 5 |
2D NCACX |
1-2 mg selectively and uniformly labeled samples beta-amyloid peptide |
10 |
none |
7.4 |
ambient |
288 |
| 6 |
2D 13C-13C with spin diffusion |
1-2 mg selectively and uniformly labeled samples beta-amyloid peptide |
10 |
none |
7.4 |
ambient |
288 |
| 7 |
2D 13C-13C with RAD |
1-2 mg selectively and uniformly labeled samples beta-amyloid peptide |
10 |
none |
7.4 |
ambient |
288 |
| 8 |
2D 13C-13C with PAR |
1-2 mg selectively and uniformly labeled samples beta-amyloid peptide |
10 |
none |
7.4 |
ambient |
288 |
| 9 |
2D 15N-13C TEDOR |
1-2 mg selectively and uniformly labeled samples beta-amyloid peptide |
10 |
none |
7.4 |
ambient |
288 |
| 10 |
2D 15N-13C TEDOR |
1-2 mg selectively and uniformly labeled samples beta-amyloid peptide |
10 |
none |
7.4 |
ambient |
288 |
| 11 |
15N- and 13C-BARE |
1-2 mg selectively and uniformly labeled samples beta-amyloid peptide |
10 |
none |
7.4 |
ambient |
288 |
| 12 |
13C PITHIRDS-CT |
1-2 mg selectively and uniformly labeled samples beta-amyloid peptide |
10 |
none |
7.4 |
ambient |
288 |
| 13 |
2D 13C-13C with fpRFDR |
1-2 mg selectively and uniformly labeled samples beta-amyloid peptide |
10 |
none |
7.4 |
ambient |
288 |